We are live on ! Find out more
HCM

Highline Capital Management Portfolio holdings

AUM $53.5M
1-Year Est. Return 21.72%
This Fund
S&P 500
This Quarter Est. Return
+38.24%
1 Year Est. Return
-21.72%
3 Year Est. Return
+197.64%
5 Year Est. Return
+251.63%
10 Year Est. Return
AUM
$123M
AUM Growth
-$288M
Cap. Flow
-$347M
Cap. Flow %
-282.17%
Top 10 Hldgs %
73.36%
Holding
33
New
8
Increased
1
Reduced
10
Closed
14

Top Buys

Rank Stock Value
1
PASG icon
Passage Bio
PASG
+$6.26M
2
SPLK
Splunk Inc
SPLK
+$6.15M
3
MA icon
Mastercard
MA
+$5.47M
4
CB icon
Chubb
CB
+$4.45M
5
EXAS
Exact Sciences
EXAS
+$4.04M

Top Sells

Rank Stock Value
1
CTLT
CATALENT, INC.
CTLT
+$35M
2
AMZN icon
Amazon
AMZN
+$34M
3
VRSN icon
VeriSign
VRSN
+$29.1M
4
BABA icon
Alibaba
BABA
+$25.6M
5
CRM icon
Salesforce
CRM
+$25.5M

Sector Composition

Rank Sector Weight
1 Healthcare 33.24%
2 Technology 23.09%
3 Consumer Discretionary 21.63%
4 Financials 11.88%
5 Communication Services 9.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HUM icon
26
Humana
HUM
$47.6B
-49,300
Closed -$15.5M
JD icon
27
JD.com
JD
$36.6B
-522,400
Closed -$21.2M
MRNA icon
28
Moderna
MRNA
$57.4B
-250,000
Closed -$7.49M
RNG icon
29
RingCentral
RNG
$6.05B
-78,000
Closed -$16.5M
UPWK icon
30
Upwork
UPWK
$1.08B
-296,900
Closed -$1.92M
URGN icon
31
UroGen Pharma
URGN
$2.04B
-222,776
Closed -$3.97M
VLO icon
32
Valero Energy
VLO
$114B
-158,900
Closed -$7.21M
FPAC.WS
33
DELISTED
Far Point Acquisition Corporation Warrants, exercisable for one share of Class A Common Stock for $1
FPAC.WS
-310,802
Closed -$168K

Similar funds

Highline Capital Management's Q2 2020 Portfolio in Review

As of Q2 2020, Highline Capital Management held 33 positions worth $123M, down 70% from $411M the previous quarter. Its ten largest holdings account for 73% of the portfolio.

Highline Capital Management withdrew a net $347M in Q2 2020, closing 14 positions and reducing 10 holdings. Its most notable exit was Dollar General, an estimated $21.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 21% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Highline Capital Management opened a new position in Splunk Inc worth $7.72M.

  • Highline Capital Management's largest Q2 2020 buy was Splunk Inc: 38,854 shares worth $7.72M.
  • Highline Capital Management added most to Passage Bio in Q2 2020, an estimated $6.26M increase.
  • Highline Capital Management's biggest Q2 2020 reduction was CATALENT, INC., cutting an estimated $35M.
  • Highline Capital Management fully exited Dollar General in Q2 2020, selling an estimated $21.9M.
  • Highline Capital Management's ten largest holdings make up 73% of its $123M portfolio in Q2 2020.
  • Highline Capital Management opened 8 new positions and closed 14 in Q2 2020.
  • Highline Capital Management's portfolio value fell 70% quarter-over-quarter to $123M.

Based on Highline Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.